Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral and Non-insulin Injected Hypoglycemic Therapy

Completed

Conditions studied: Diabetes Mellitus, Type 2

In brief

The objective of this study is to identify EMR-based clinical covariates and quantify their association with the prescribing of each specific type 2 diabetes (T2DM) medication under investigation. This will include an assessment of how well these covariates are captured through claims data proxies, and their potential to confound comparative research of T2DM medications.

Key facts

Study ID

NCT02140645

Run by

Boehringer Ingelheim

People needed

166613

Starts

2014-05-01

Expected to finish

2015-03-01

Last updated by the study team

2017-02-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Dispensing of an oral or non-insulin injected hypoglycemic medication between May 2011 and June 2012
• Diagnosis of type 2 diabetes mellitus
• Presence of electronic medical records (for the EMR-based subset)

You may not qualify if…

• Age <18 at T2DM medication initiation
• Missing or ambiguous age or sex information
• At least one diagnosis of type 1 diabetes mellitus
• Less than 6 months enrolment in the database preceding the date of the first dispensing
• Prior use of the index drug

Where it is running

• Boehringer Ingelheim Investigational Site — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.